GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Accumulated other comprehensive income (loss)

Samsung BioLogics Co (XKRX:207940) Accumulated other comprehensive income (loss) : ₩0 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Samsung BioLogics Co's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was ₩0 Mil.

Samsung BioLogics Co Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Samsung BioLogics Co's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co Accumulated other comprehensive income (loss) Chart

Samsung BioLogics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Samsung BioLogics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Samsung BioLogics Co Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Samsung BioLogics Co Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Samsung BioLogics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
XKRX:068270 XKRX:196170 XKRX:326030 XKRX:028300 XKRX:087010 XKRX:214450 XKRX:141080 XKRX:145020 XKRX:302440 XKRX:950160 VRTX ASX:CSL REGN ALNY XBRU:ARGX XBRU:UCB ONC BNTX SMMT RPRX
Traded in Other Exchanges
N/A
Address
125, Cheomdan-daero, Yeonsu-gu, Incheon, KOR
Website
https://www.samsungbiologics.com
Founded in 2011, Samsung Biologics is a South Korean contract development and manufacturing organization with a global client base. Europe and the US contribute 90% of its total revenue. It provides end-to-end development and manufacturing services from cell line developments to final commercial manufacturing. As of 2023, Samsung Biologics had a total production capacity of 604,000 liters, one of the largest in the world. Its CDMO services account for 72.4% of its total revenue. The balance comes from subsidiary Samsung Bioepis, acquired in 2022. Samsung Bioepis is involved in developing and manufacturing biosimilars.

Samsung BioLogics Co Headlines

No Headlines